Works by Cassier, Philippe A.


Results: 76
    1
    2

    Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma.

    Published in:
    EJHaem, 2022, v. 3, n. 1, p. 139, doi. 10.1002/jha2.375
    By:
    • Ribrag, Vincent;
    • Chavez, Julio C.;
    • Boccomini, Carola;
    • Kaplan, Jason;
    • Chandler, Jason C.;
    • Santoro, Armando;
    • Corradini, Paolo;
    • Flinn, Ian W.;
    • Advani, Ranjana;
    • Cassier, Philippe A.;
    • Sangha, Randeep;
    • Kenkre, Vaishalee P.;
    • Isufi, Iris;
    • Uttamsingh, Shailaja;
    • Hagner, Patrick R.;
    • Gandhi, Anita K.;
    • Shen, Frank;
    • Michelliza, Sophie;
    • Haeske, Harald;
    • Hege, Kristen
    Publication type:
    Article
    3

    Barriers to publishing early phase clinical trials: the oncologists' perspective.

    Published in:
    Oncologist, 2025, v. 30, n. 4, p. 1, doi. 10.1093/oncolo/oyaf042
    By:
    • Lucassen, Merel J J;
    • Bergmann, Pedro;
    • Husson, Olga;
    • Banerji, Udai;
    • Basu, Bristi;
    • Melero, Ignacio;
    • Calvo, Emiliano;
    • Cassier, Philippe A;
    • Drilon, Alexander;
    • Fong, Peter C;
    • Garralda, Elena;
    • Joshua, Anthony M;
    • Lin, Chia-Chi;
    • Lopez, Juanita;
    • Moreno, Victor;
    • Minchom, Anna;
    • Plummer, Ruth;
    • Postel-Vinay, Sophie;
    • Spreafico, Anna;
    • Shimizu, Toshio
    Publication type:
    Article
    4
    5
    6

    Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

    Published in:
    Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1
    By:
    • Rhoda Molife, L.;
    • Li Yan;
    • Vitfell-Rasmussen, Joanna;
    • Zernhelt, Adriane M.;
    • Sullivan, Daniel M.;
    • Cassier, Philippe A.;
    • Eric Chen;
    • Biondo, Andrea;
    • Tetteh, Ernestina;
    • Siu, Lillian L.;
    • Patnaik, Amita;
    • Papadopoulos, Kyriakos P.;
    • De Bono, Johann S.;
    • Tolcher, Anthony W.;
    • Minton, Susan
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.

    Published in:
    2020
    By:
    • Le Tourneau, Christophe;
    • Delord, Jean-Pierre;
    • Kotecki, Nuria;
    • Borcoman, Edith;
    • Gomez-Roca, Carlos;
    • Hescot, Ségolène;
    • Jungels, Christiane;
    • Vincent-Salomon, Anne;
    • Cockenpot, Vincent;
    • Eberst, Lauriane;
    • Molé, Audrey;
    • Jdey, Wael;
    • Bono, Françoise;
    • Trochon-Joseph, Véronique;
    • Toussaint, Hélène;
    • Zandanel, Christelle;
    • Adamiec, Olga;
    • de Beaumont, Olivier;
    • Cassier, Philippe Alexandre
    Publication type:
    journal article
    14
    15
    16
    17

    Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study.

    Published in:
    Supportive Care in Cancer, 2024, v. 32, n. 6, p. 1, doi. 10.1007/s00520-024-08535-x
    By:
    • Lochmann, Mathilde;
    • Girodet, Magali;
    • Despax, Johanna;
    • Baudry, Valentine;
    • Duranti, Julie;
    • Mastroianni, Bénédicte;
    • Vanacker, Hélène;
    • Vinceneux, Armelle;
    • Brahmi, Mehdi;
    • Renard, Olivier;
    • Verlingue, Loïc;
    • Amini-Adle, Mona;
    • Swalduz, Aurélie;
    • Gautier, Julien;
    • Ducimetière, Françoise;
    • Anota, Amélie;
    • Cassier, Philippe A.;
    • Chvetzoff, Gisèle;
    • Christophe, Véronique
    Publication type:
    Article
    18
    19
    20
    21

    Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT).

    Published in:
    PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0233046
    By:
    • Brahmi, Mehdi;
    • Cassier, Philippe;
    • Dufresne, Armelle;
    • Chabaud, Sylvie;
    • Karanian, Marie;
    • Meurgey, Alexandra;
    • Bouhamama, Amine;
    • Gouin, Francois;
    • Vaz, Gualter;
    • Garret, Jerome;
    • Sunyach, Marie-Pierre;
    • Dupré, Aurélien;
    • Marec-Berard, Perrine;
    • Corradini, Nadège;
    • Perol, David;
    • Ray-Coquard, Isabelle;
    • Blay, Jean-Yves
    Publication type:
    Article
    22

    Pharmacokinetics of pazopanib administered in combination with bevacizumab.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 6, p. 1189, doi. 10.1007/s00280-014-2455-3
    By:
    • Imbs, Diane-Charlotte;
    • Négrier, Sylvie;
    • Cassier, Philippe;
    • Hollebecque, Antoine;
    • Varga, Andrea;
    • Blanc, Ellen;
    • Lafont, Thierry;
    • Escudier, Bernard;
    • Soria, Jean-Charles;
    • Pérol, David;
    • Chatelut, Etienne
    Publication type:
    Article
    23

    Pazopanib for the treatment of soft-tissue sarcoma.

    Published in:
    Clinical Pharmacology, 2012, v. 4, p. 65
    By:
    • Heudel, Pierre;
    • Cassier, Philippe;
    • Derbel, Olfa;
    • Dufresne, Armelle;
    • Meeus, Pierre;
    • Thiesse, Philippe;
    • Ranchère-Vince, Dominique;
    • Blay, Jean Yves;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    24

    Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort).

    Published in:
    PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0158406
    By:
    • Derbel, Olfa;
    • Heudel, Pierre Etienne;
    • Cropet, Claire;
    • Meeus, Pierre;
    • Vaz, Gualter;
    • Biron, Pierre;
    • Cassier, Philippe;
    • Decouvelaere, Anne-Valérie;
    • Ranchere-Vince, Dominique;
    • Collard, Olivier;
    • De Laroche, Eric;
    • Thiesse, Philippe;
    • Farsi, Fadila;
    • Cellier, Dominic;
    • Gilly, François-Noel;
    • Blay, Jean-Yves;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    25
    26
    27

    SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.

    Published in:
    Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03994-6
    By:
    • Bertrand-Chapel, Adrien;
    • Caligaris, Cassandre;
    • Fenouil, Tanguy;
    • Savary, Clara;
    • Aires, Sophie;
    • Martel, Sylvie;
    • Huchedé, Paul;
    • Chassot, Christelle;
    • Chauvet, Véronique;
    • Cardot-Ruffino, Victoire;
    • Morel, Anne-Pierre;
    • Subtil, Fabien;
    • Mohkam, Kayvan;
    • Mabrut, Jean-Yves;
    • Tonon, Laurie;
    • Viari, Alain;
    • Cassier, Philippe;
    • Hervieu, Valérie;
    • Castets, Marie;
    • Mauviel, Alain
    Publication type:
    Article
    28

    A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.

    Published in:
    OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2023.2290787
    By:
    • Lin, Chia-Chi;
    • Garralda, Elena;
    • Schöffski, Patrick;
    • Hong, David S.;
    • Siu, Lillian L.;
    • Martin, Miguel;
    • Maur, Michela;
    • Hui, Rina;
    • Soo, Ross A;
    • Chiu, Joanne;
    • Zhang, Tian;
    • Ma, Brigette;
    • Kyi, Chrisann;
    • Tan, Daniel SW;
    • Cassier, Philippe A.;
    • Sarantopoulos, John;
    • Weickhardt, Andrew;
    • Carvajal, Richard D.;
    • Spratlin, Jennifer;
    • Esaki, Taito
    Publication type:
    Article
    29

    Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub‐analysis of the ProfiLER protocol.

    Published in:
    Head & Neck, 2021, v. 43, n. 12, p. 3899, doi. 10.1002/hed.26891
    By:
    • Rowinski, Elise;
    • Magné, Nicolas;
    • Fayette, Jérôme;
    • Daguenet, Elisabeth;
    • Racadot, Séverine;
    • Pommier, Pascal;
    • Méry, Benoîte;
    • Vallard, Alexis;
    • Tinquaut, Fabien;
    • Neidhardt‐Berard, Eve‐Marie;
    • Cassier, Philippe;
    • Attignon, Valéry;
    • Pissaloux, Daniel;
    • Wang, Qing;
    • Sohier, Emilie;
    • Pérol, David;
    • Blay, Jean‐Yves;
    • Trédan, Olivier
    Publication type:
    Article
    30

    A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.

    Published in:
    Breast Cancer Research & Treatment, 2008, v. 109, n. 2, p. 343, doi. 10.1007/s10549-007-9651-3
    By:
    • Philippe Cassier;
    • Sylvie Chabaud;
    • Véronique Trillet-Lenoir;
    • Pierre-Yves Peaud;
    • Jean-Dominique Tigaud;
    • Hervé Cure;
    • Hubert Orfeuvre;
    • Bruno Salles;
    • Claude Martin;
    • Jean-Philippe Jacquin;
    • Cecile Agostini;
    • Jean-Paul Guastalla;
    • David Pérol;
    • Thomas Bachelot
    Publication type:
    Article
    31
    32

    Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium.

    Published in:
    Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00832
    By:
    • Ray-Coquard, Isabelle;
    • Braicu, Ioana;
    • Berger, Regina;
    • Mahner, Sven;
    • Sehouli, Jalid;
    • Pujade-Lauraine, Eric;
    • Cassier, Philippe Alexandre;
    • Moll, Ute Martha;
    • Ulmer, Hanno;
    • Leunen, Karin;
    • Zeimet, Alain Gustave;
    • Marth, Christian;
    • Vergote, Ignace;
    • Concin, Nicole
    Publication type:
    Article
    33
    34
    35

    A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.

    Published in:
    2018
    By:
    • Giraudet, Anne-Laure;
    • Cassier, Philippe Alexandre;
    • Iwao-Fukukawa, Chicaco;
    • Garin, Gwenaelle;
    • Badel, Jean-Noël;
    • Kryza, David;
    • Chabaud, Sylvie;
    • Gilles-Afchain, Laurence;
    • Clapisson, Gilles;
    • Desuzinges, Claude;
    • Sarrut, David;
    • Halty, Adrien;
    • Italiano, Antoine;
    • Mori, Masaharu;
    • Tsunoda, Takuya;
    • Katagiri, Toyomasa;
    • Nakamura, Yusuke;
    • Alberti, Laurent;
    • Cropet, Claire;
    • Baconnier, Simon
    Publication type:
    journal article
    36

    A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 4, p. 1089, doi. 10.1007/s10637-021-01094-6
    By:
    • Azaro, Analia;
    • Massard, Christophe;
    • Tap, William D.;
    • Cassier, Philippe A.;
    • Merchan, Jaime;
    • Italiano, Antoine;
    • Anderson, Bailey;
    • Yuen, Eunice;
    • Yu, Danni;
    • Oakley III, Gerard;
    • Benhadji, Karim A.;
    • Pant, Shubham
    Publication type:
    Article
    37
    38

    First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 417, doi. 10.1007/s00262-021-02973-w
    By:
    • Italiano, Antoine;
    • Cassier, Philippe A.;
    • Lin, Chia-Chi;
    • Alanko, Tuomo;
    • Peltola, Katriina J.;
    • Gazzah, Anas;
    • Shiah, Her-Shyong;
    • Calvo, Emiliano;
    • Cervantes, Andrés;
    • Roda, Desamparados;
    • Tosi, Diego;
    • Gao, Bo;
    • Millward, Michael;
    • Warburton, Lydia;
    • Tanner, Minna;
    • Englert, Stefan;
    • Lambert, Stacie;
    • Parikh, Apurvasena;
    • Afar, Daniel E.;
    • Vosganian, Gregory
    Publication type:
    Article
    39

    Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7115
    By:
    • Dufresne, Armelle;
    • Attignon, Valéry;
    • Ferrari, Anthony;
    • Tonon, Laurie;
    • Boyault, Sandrine;
    • Tabone‐Eglinger, Séverine;
    • Cassier, Philippe;
    • Trédan, Olivier;
    • Corradini, Nadège;
    • Vinceneux, Armelle;
    • Swalduz, Aurélie;
    • Viari, Alain;
    • Chabaud, Sylvie;
    • Pérol, David;
    • Blay, Jean Yves;
    • Saintigny, Pierre
    Publication type:
    Article
    40

    Expanding the molecular spectrum of tenosynovial giant cell tumors.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1012527
    By:
    • Gauduchon, Thibault;
    • Vanacker, Helene;
    • Pissaloux, Daniel;
    • Cassier, Philippe;
    • Dufresne, Armelle;
    • Karanian, Marie;
    • Meurgey, Alexandra;
    • Bouhamama, Amine;
    • Gouin, François;
    • Ray-Coquard, Isabelle;
    • Blay, Jean-Yves;
    • Tirode, Franck;
    • Brahmi, Mehdi
    Publication type:
    Article
    41

    The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1379777
    By:
    • Voisin, Allison;
    • Plaschka, Maud;
    • Perrin-Niquet, Marlène;
    • Twardowski, Julie;
    • Boutemine, Insaf;
    • Eluard, Baptiste;
    • Lalle, Guilhem;
    • Stéphan, Pierre;
    • Bouherrou, Khaled;
    • Tonon, Laurie;
    • Pommier, Roxane;
    • Ferrari, Anthony;
    • Klein, Ulf;
    • Wencker, Mélanie;
    • Baud, Véronique;
    • Cassier, Philippe A.;
    • Grinberg-Bleyer, Yenkel
    Publication type:
    Article
    42

    Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.

    Published in:
    Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363
    By:
    • Subbiah, Vivek;
    • Hu, Mimi I.;
    • Mansfield, Aaron S.;
    • Taylor, Matthew H.;
    • Schuler, Martin;
    • Zhu, Viola W.;
    • Hadoux, Julien;
    • Curigliano, Giuseppe;
    • Wirth, Lori;
    • Gainor, Justin F.;
    • Alonso, Guzman;
    • Adkins, Douglas;
    • Godbert, Yann;
    • Ahn, Myung-Ju;
    • Cassier, Philippe A.;
    • Cho, Byoung Chul;
    • Lin, Chia-Chi;
    • Zalutskaya, Alena;
    • Barata, Teresa;
    • Trask, Peter
    Publication type:
    Article
    43
    44

    Model Informed Dosing Regimen and Phase I Results of the Anti‐PD‐1 Antibody Budigalimab (ABBV‐181).

    Published in:
    CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 277, doi. 10.1111/cts.12855
    By:
    • Powderly, John;
    • Spira, Alexander;
    • Kondo, Shunsuke;
    • Doi, Toshihiko;
    • Luke, Jason J.;
    • Rasco, Drew;
    • Gao, Bo;
    • Tanner, Minna;
    • Cassier, Philippe A.;
    • Gazzah, Anas;
    • Italiano, Antoine;
    • Tosi, Diego;
    • Afar, Daniel E.;
    • Parikh, Apurvasena;
    • Engelhardt, Benjamin;
    • Englert, Stefan;
    • Lambert, Stacie L.;
    • Kasichayanula, Sreeneeranj;
    • Mensing, Sven;
    • Menon, Rajeev
    Publication type:
    Article
    45

    Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).

    Published in:
    2018
    By:
    • Montemurro, Michael;
    • Cioffi, Angela;
    • Dômont, Julien;
    • Rutkowski, Piotr;
    • Roth, Arnaud D.;
    • von Moos, Roger;
    • Inauen, Roman;
    • Toulmonde, Maud;
    • Burkhard, Roger O.;
    • Knuesli, Claudio;
    • Bauer, Sebastian;
    • Cassier, Philippe;
    • Schwarb, Heike;
    • Le Cesne, Axel;
    • Koeberle, Dieter;
    • Bärtschi, Daniela;
    • Dietrich, Daniel;
    • Biaggi, Christine;
    • Prior, John;
    • Leyvraz, Serge
    Publication type:
    journal article
    46
    47
    48

    Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.

    Published in:
    Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02092-x
    By:
    • Cousin, Sophie;
    • Guégan, Jean-Philippe;
    • Shitara, Kohei;
    • Palmieri, Lola Jade;
    • Metges, Jean Philippe;
    • Pernot, Simon;
    • Fukuoka, Shota;
    • Koyama, Shohei;
    • Nishikawa, Hiroyoshi;
    • Bellera, Carine A.;
    • Adenis, Antoine;
    • Gomez-Roca, Carlos A.;
    • Cassier, Philippe Alexandre;
    • Hollebecque, Antoine;
    • Cantarel, Coralie;
    • Kind, Michèle;
    • Soubeyran, Isabelle;
    • Vanhersecke, Lucile;
    • Bessede, Alban;
    • Italiano, Antoine
    Publication type:
    Article
    49

    Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3441, doi. 10.3390/cancers15133441
    By:
    • Trédan, Olivier;
    • Toulmonde, Maud;
    • Le Tourneau, Christophe;
    • Montane, Laure;
    • Italiano, Antoine;
    • Ray-Coquard, Isabelle;
    • De La Fouchardière, Christelle;
    • Bertucci, François;
    • Gonçalves, Anthony;
    • Gomez-Roca, Carlos;
    • You, Benoit;
    • Attignon, Valéry;
    • Boyault, Sandrine;
    • Cassier, Philippe A.;
    • Dufresne, Armelle;
    • Tabone-Eglinger, Séverine;
    • Viari, Alain;
    • Sohier, Emilie;
    • Kamal, Maud;
    • Garin, Gwenaël
    Publication type:
    Article
    50

    Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-156
    By:
    • Thanh-Khoa Huynh;
    • Meeus, Pierre;
    • Cassier, Philippe;
    • Bouché, Olivier;
    • Lardière-Deguelte, Sophie;
    • Adenis, Antoine;
    • André, Thierry;
    • Mancini, Julien;
    • Collard, Olivier;
    • Montemurro, Michael;
    • Bompas, Emmanuelle;
    • Rios, Maria;
    • Isambert, Nicolas;
    • Cupissol, Didier;
    • Blay, Jean-Yves;
    • Duffaud, Florence
    Publication type:
    Article